Literature DB >> 21479594

The role of chemokines and their receptors in angiogenesis.

Friedemann Kiefer1, Arndt F Siekmann.   

Abstract

Chemokines are a vertebrate-specific group of small molecules that regulate cell migration and behaviour in diverse contexts. So far, around 50 chemokines have been identified in humans, which bind to 18 different chemokine receptors. These are members of the seven-transmembrane receptor family. Initially, chemokines were identified as modulators of the immune response. Subsequently, they were also shown to regulate cell migration during embryonic development. Here, we discuss the influence of chemokines and their receptors on angiogenesis, or the formation of new blood vessels. We highlight recent advances in our understanding of how chemokine signalling might directly influence endothelial cell migration. We furthermore examine the contributions of chemokine signalling in immune cells during this process. Finally, we explore possible implications for disease settings, such as chronic inflammation and tumour progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479594     DOI: 10.1007/s00018-011-0677-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  215 in total

1.  The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages.

Authors:  R E Mebius; T Miyamoto; J Christensen; J Domen; T Cupedo; I L Weissman; K Akashi
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 2.  Chemokines as mediators of tumor angiogenesis and neovascularization.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Exp Cell Res       Date:  2010-10-30       Impact factor: 3.905

3.  Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.

Authors:  C Perollet; Z C Han; C Savona; J P Caen; A Bikfalvi
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

4.  Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.

Authors:  V Jouan; X Canron; M Alemany; J P Caen; G Quentin; J Plouet; A Bikfalvi
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

5.  Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1.

Authors:  V Goede; L Brogelli; M Ziche; H G Augustin
Journal:  Int J Cancer       Date:  1999-08-27       Impact factor: 7.396

6.  Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

Authors:  Yukiko Ueda; Nicole F Neel; Evemie Schutyser; Dayanidhi Raman; Ann Richmond
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

7.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

Authors:  Chiara Porta; Monica Rimoldi; Geert Raes; Lea Brys; Pietro Ghezzi; Diana Di Liberto; Francesco Dieli; Serena Ghisletti; Gioacchino Natoli; Patrick De Baetselier; Alberto Mantovani; Antonio Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

8.  Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

Authors:  D A Arenberg; M P Keane; B DiGiovine; S L Kunkel; S B Morris; Y Y Xue; M D Burdick; M C Glass; M D Iannettoni; R M Strieter
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

9.  Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.

Authors:  Martin Kleinhans; Adrian Tun-Kyi; Michel Gilliet; Marshall E Kadin; Reinhard Dummer; Günter Burg; Frank O Nestle
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.

Authors:  Masahiro Ohta; Yasuhiko Kitadai; Shinji Tanaka; Masaharu Yoshihara; Wataru Yasui; Naofumi Mukaida; Ken Haruma; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2002-11-20       Impact factor: 7.396

View more
  50 in total

1.  Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.

Authors:  Zhongyang Lu; Yanchun Li; Junfei Jin; Xiaoming Zhang; Maria F Lopes-Virella; Yan Huang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

2.  Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.

Authors:  Fei Yu; Tian Tian; Bin Deng; Tianpei Wang; Qi Qi; Meng Zhu; Caiwang Yan; Hui Ding; Jinchen Wang; Juncheng Dai; Hongxia Ma; Yanbing Ding; Guangfu Jin
Journal:  Gastric Cancer       Date:  2018-06-01       Impact factor: 7.370

3.  Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Authors:  Je-Hung Kuo; Ya-Ping Chen; Jai-Shin Liu; Alexandre Dubrac; Cathy Quemener; Hervé Prats; Andreas Bikfalvi; Wen-guey Wu; Shih-Che Sue
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

4.  Knockdown of CXCL14 disrupts neurovascular patterning during ocular development.

Authors:  Ana F Ojeda; Ravi P Munjaal; Peter Y Lwigale
Journal:  Dev Biol       Date:  2017-01-15       Impact factor: 3.582

5.  The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.

Authors:  Vincent Vanheule; Rik Janssens; Daiane Boff; Nikola Kitic; Nele Berghmans; Isabelle Ronsse; Andreas J Kungl; Flavio Almeida Amaral; Mauro Martins Teixeira; Jo Van Damme; Paul Proost; Anneleen Mortier
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

Review 6.  The chemokine superfamily revisited.

Authors:  Albert Zlotnik; Osamu Yoshie
Journal:  Immunity       Date:  2012-05-25       Impact factor: 31.745

7.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.

Authors:  Sajjad Khan; Silke Cameron; Martina Blaschke; Federico Moriconi; Naila Naz; Ahmad Amanzada; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

9.  Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.

Authors:  M Mehrabani; M Najafi; T Kamarul; K Mansouri; M Iranpour; M H Nematollahi; M Ghazi-Khansari; A M Sharifi
Journal:  Cell Prolif       Date:  2015-10       Impact factor: 6.831

10.  Expression of CXCL12 and CXCL14 during eye development in chick and mouse.

Authors:  Ana F Ojeda; Ravi P Munjaal; Peter Y Lwigale
Journal:  Gene Expr Patterns       Date:  2013-05-30       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.